Walleye Capital’s Bio-Techne TECH Stock Holding History

Walleye Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$170K	Sell	2,401 -130,006	-98%	-$7.02M	﹤0.01%	3597
2026 Q1	$6.92M	Sell	132,407 -8,061	-6%	-$484K	0.03%	599
2025 Q4	$8.26M	Sell	140,468 -302,706	-68%	-$18.4M	0.03%	784
2025 Q3	$24.7M	Buy	+443,174	New	+$23.7M	0.09%	193
2025 Q2	–	Sell	-57,315	Closed	-$2.88M	–	5027
2025 Q1	$3.36M	Buy	+57,315	New	+$3.88M	0.02%	1060
2024 Q4	–	Sell	-1,685	Closed	-$135K	–	5546
2024 Q3	$135K	Sell	1,685 -30,813	-95%	-$2.32M	﹤0.01%	4253
2024 Q2	$2.33M	Buy	32,498 +30,711	+1,719%	+$2.26M	﹤0.01%	1961
2024 Q1	$126K	Buy	+1,787	New	+$128K	﹤0.01%	4266
2023 Q2	–	Sell	-2,372	Closed	-$191K	–	4872
2023 Q1	$176K	Sell	2,372 -659	-22%	-$50.8K	﹤0.01%	2562
2022 Q4	$251K	Buy	+3,031	New	+$241K	﹤0.01%	1902
2022 Q2	–	Sell	-5,376	Closed	-$582K	–	2716
2022 Q1	$582K	Buy	+5,376	New	+$555K	0.02%	930

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Walleye Capital's TECH Position: Q2 2026 in Review

Walleye Capital reduced its Bio-Techne (TECH) stake by 98% in Q2 2026, selling an estimated $7.02M and leaving 2,401 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #3597.

Walleye Capital first reported a position in TECH in Q1 2022 and has held it in 11 quarters since. The position peaked at $24.7M in Q3 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Walleye Capital held 2,401 shares of Bio-Techne worth $170K as of Q2 2026.
Walleye Capital sold 130,006 Bio-Techne shares in Q2 2026, an estimated $7.02M.
Bio-Techne made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3597 holding.
Walleye Capital first reported a position in Bio-Techne in Q1 2022 and has held it in 11 quarters since.
Walleye Capital's Bio-Techne position peaked at $24.7M in Q3 2025.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.